Glycosylation profile of IgG in moderate kidney dysfunction

Journal of the American Society of Nephrology

Volumn 27, Issue 3, 2016, Pages 933-941

  Barrios, Clara ^a,b   Zierer, Jonas ^a,c   Gudelj, Ivan ^d   Stambuk, Jerko ^d   Ugrina, Ivo ^d   Rodríguez, Eva ^b   Soler, María José ^b   Pavic, Tamara ^e   Simurina, Mirna ^e   Keser, Toma ^e   Pucic Bakovic, Maja ^c   Mangino, Massimo ^a   Pascual, Julio ^b   Spector, Tim D ^a   Lauc, Gordan ^c,e   Menni, Cristina ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HOSPITAL DEL MAR   (Spain)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^e UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; IMMUNOGLOBULIN G; AGALACTOSYL IGG; GALACTOSE; N ACETYLGLUCOSAMINE; POLYSACCHARIDE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DEGLYCOSYLATION; FEMALE; GALACTOSYLATION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; MALE; MIDDLE AGED; MILD RENAL IMPAIRMENT; MONOZYGOTIC TWINS; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIALYLATION; SYNAPOMORPHY; TWIN DISCORDANCE; ADOLESCENT; AGED; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; CHRONIC KIDNEY FAILURE; GLYCOSYLATION; META ANALYSIS; METABOLISM; PATHOPHYSIOLOGY; TWINS; VERY ELDERLY; YOUNG ADULT;

ACETYLGLUCOSAMINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GALACTOSE; GLOMERULAR FILTRATION RATE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; POLYSACCHARIDES; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84959889208     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010109     Document Type: Article

References (46)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
2. Coresh J, Selvin E, Stevens LA,Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
3. Pattaro C, Köttgen A, Teumer A, GarnaasM, Böger CA, Fuchsberger C, Olden M, Chen MH, Tin A, Taliun D, Li M, Gao X, Gorski M, Yang Q, Hundertmark C, Foster MC, O'Seaghdha CM, Glazer N, Isaacs A, Liu CT, Smith AV, O'Connell JR, StruchalinM, Tanaka T, Li G, Johnson AD, Gierman HJ, Feitosa M, Hwang SJ, Atkinson EJ, Lohman K, Cornelis MC, Johansson Å, Tönjes A, Dehghan A, Chouraki V, Holliday EG, Sorice R, Kutalik Z, Lehtimäki T, Esko T, Deshmukh H, Ulivi S, Chu AY, Murgia F, Trompet S, Imboden M, Kollerits B, Pistis G, Harris TB, Launer LJ, Aspelund T, Eiriksdottir G, Mitchell BD, Boerwinkle E, Schmidt H, Cavalieri M, Rao M, Hu FB, Demirkan A, Oostra BA, de Andrade M, Turner ST, Ding J, Andrews JS, Freedman BI, Koenig W, Illig T, Döring A,Wichmann HE, Kolcic I, Zemunik T, BobanM,Minelli C, Wheeler HE, Igl W, Zaboli G, Wild SH, Wright AF, Campbell H, Ellinghaus D, Nöthlings U, Jacobs G, Biffar R, Endlich K, Ernst F, Homuth G, Kroemer HK,Nauck M, Stracke S, Völker U, Völzke H, Kovacs P, StumvollM,Mägi R, Hofman A, Uitterlinden AG, Rivadeneira F, Aulchenko YS, Polasek O, Hastie N, Vitart V, Helmer C, Wang JJ, Ruggiero D, Bergmann S, Kähönen M, Viikari J, Nikopensius T, Province M, Ketkar S, Colhoun H, Doney A, Robino A, Giulianini F, Krämer BK, Portas L, Ford I, Buckley BM, Adam M, Thun GA, Paulweber B, Haun M, Sala C, Metzger M, Mitchell P, Ciullo M, Kim SK, Vollenweider P, Raitakari O, Metspalu A, Palmer C, Gasparini P, Pirastu M, Jukema JW, Probst-Hensch NM, Kronenberg F, Toniolo D, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Siscovick DS, van Duijn CM, Borecki I, Kardia SL, Liu Y, Curhan GC, Rudan I, Gyllensten U, Wilson JF, Franke A, Pramstaller PP, Rettig R, Prokopenko I,Witteman JC,HaywardC, Ridker P, Parsa A, BochudM,Heid IM, GoesslingW, ChasmanDI, KaoWH, Fox CS; CARDIoGRAM Consortium; ICBP Consortium; CARe Consortium; Wellcome Trust Case Control Consortium 2 (WTCCC2): Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 8: e1002584, 2012
4. Okada Y, Sim X, Go MJ,Wu JY, Gu D, Takeuchi F, Takahashi A, Maeda S, Tsunoda T, Chen P, Lim SC, Wong TY, Liu J, Young TL, Aung T, SeielstadM, Teo YY, KimYJ, Lee JY, Han BG, Kang D, Chen CH, Tsai FJ, Chang LC, Fann SJ,Mei H, Rao DC, Hixson JE, Chen S, Katsuya T, Isono M, Ogihara T, Chambers JC, Zhang W, Kooner JS, Albrecht E, Yamamoto K, Kubo M, Nakamura Y, Kamatani N, Kato N, He J, Chen YT, Cho YS, Tai ES, Tanaka T; KidneyGen Consortium; CKDGen Consortium; GUGC consortium: Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet 44: 904-909, 2012
5. Köttgen A, Pattaro C, Böger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, O'Connell JR, Li M, Schmidt H, Tanaka T, Isaacs A, Ketkar S, Hwang SJ, Johnson AD, Dehghan A, Teumer A, Paré G, Atkinson EJ, Zeller T, Lohman K, Cornelis MC, Probst-Hensch NM, Kronenberg F, Tönjes A, Hayward C, Aspelund T, Eiriksdottir G, Launer LJ, Harris TB, Rampersaud E, Mitchell BD, Arking DE, Boerwinkle E, Struchalin M, Cavalieri M, Singleton A, Giallauria F, Metter J, de Boer IH, Haritunians T, Lumley T, Siscovick D, Psaty BM, Zillikens MC, Oostra BA, FeitosaM, Province M, de Andrade M, Turner ST, Schillert A, Ziegler A, Wild PS, Schnabel RB, Wilde S, Munzel TF, Leak TS, Illig T, Klopp N,Meisinger C, Wichmann HE, KoenigW, Zgaga L, Zemunik T, Kolcic I, Minelli C, Hu FB, Johansson A, Igl W, Zaboli G, Wild SH,Wright AF, Campbell H, Ellinghaus D, Schreiber S, Aulchenko YS, Felix JF, Rivadeneira F, Uitterlinden AG, Hofman A, Imboden M, Nitsch D, Brandstätter A, Kollerits B, Kedenko L, Mägi R, Stumvoll M, Kovacs P, Boban M, Campbell S, Endlich K, Völzke H, Kroemer HK, NauckM, Völker U, PolasekO, Vitart V, Badola S, Parker AN, Ridker PM, Kardia SL, Blankenberg S, Liu Y, Curhan GC, Franke A, Rochat T, Paulweber B, Prokopenko I, Wang W, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Shlipak MG, van Duijn CM, Borecki I, Krämer BK, Rudan I, Gyllensten U,Wilson JF,Witteman JC, Pramstaller PP, Rettig R, HastieN, Chasman DI, KaoWH, Heid IM, Fox CS: New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-384, 2010
6. Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet 365: 331-340, 2005
7. BochudM, Elston RC,MaillardM, Bovet P, Schild L, ShamlayeC, Burnier M: Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). Kidney Int 67: 61-69, 2005
8. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI: Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 43: 796-800, 2004
9. National Research Council: Committee on Assessing the Importance and Impact of Glycomics and Glycosciences. Transforming Glycoscience: A Roadmap for the Future, Washington, D. C., The National Academies Press, 2012
10. GornikO, Pavic T, LaucG: Alternative glycosylation modulates function of IgG and other proteins-implications on evolution and disease. Biochim Biophys Acta 1820: 1318-1326, 2012
11. JangHR, RabbH: Immune cells in experimental acute kidney injury. Nat Rev Nephrol 11: 88-101, 2015
12. Lauc G, Huffman JE, Pucic M, Zgaga L, Adamczyk B, Muzînic A, Novokmet M, Pola͉ek O, Gornik O, Kri͉tic J, Keser T, Vitart V, Scheijen B, UhHW,MolokhiaM, Patrick AL,McKeigue P, Kolcic I, Lukic IK, Swann O, van Leeuwen FN, Ruhaak LR, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, de Craen AJ, Deelder AM, Zeng Q, Wang W, Hastie ND, Gyllensten U,Wilson JF, WuhrerM, Wright AF, Rudd PM, Hayward C, Aulchenko Y, Campbell H, Rudan I: Loci associated with N-glycosylation of human immunoglobulinGshow pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet 9: e1003225, 2013
13. Go MF, Schrohenloher RE, Tomana M: Deficient galactosylation of serum IgG in inflammatory bowel disease: correlation with disease activity. J Clin Gastroenterol 18: 86-87, 1994
14. Trbojevic-Akmacic I, Ventham NT, Theodoratou E, Vuckovic F: kennedy, NA, Kristic, J, Nimmo, ER, Drummond, D, Stambuk, J, Klaric, L, Dunlop, MG, Novokmet, M, Aulchenko, Y, Gornik, O, Kolarich, D, Wuhrer, M, McGovern,D,Annese, V, Kalla, R, Pemberton, JM, Spencer,D, Zoldos, V, Fernandes, D, Campbell, H, Pucic Bakovic, M, Satsangi, J, Lauc, G: Inflammatory bowel disease associates with pro-inflammatory potential of the IgG glycome. Inflamm Bowel Dis 21(6): 1237-1247, 2015
15. Ohtsubo K, Marth JD: Glycosylation in cellular mechanisms of health and disease. Cell 126: 855-867, 2006
16. Gornik O, Lauc G: Glycosylation of serum proteins in inflammatory diseases. Dis Markers 25: 267-278, 2008
17. Moore JS,Wu X, Kulhavy R, TomanaM,Novak J,Moldoveanu Z, Brown R,Goepfert PA,Mestecky J: Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS 19: 381-389, 2005
18. Paragh G, Seres I, Harangi M, Fülöp P: Dynamic interplay between metabolic syndrome and immunity. Adv Exp Med Biol 824: 171-190, 2014
19. Camps J, García-Heredia A: Introduction: oxidation and inflammation, a molecular link between non-communicable diseases. Adv Exp Med Biol 824: 1-4, 2014
20. Lopez-Parra V, Mallavia B, Lopez-Franco O, Ortiz-Muñoz G, Oguiza A, Recio C, Blanco J, Nimmerjahn F, Egido J, Gomez-Guerrero C: Fcg receptor deficiency attenuates diabetic nephropathy. J Am Soc Nephrol 23: 1518-1527, 2012
21. van Timmeren MM, van der Veen BS, Stegeman CA, Petersen AH, Hellmark T, Collin M, Heeringa P: IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol 21: 1103-1114, 2010
22. Novak J, Julian BA,Mestecky J, RenfrowMB:Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 34: 365-382, 2012
23. Novak J, TomanaM, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513, 2005
24. Menni C, Keser T, Mangino M, Bell JT, Erte I, Akmacic I, Vuckovic F, Pucic BakovicM,GornikO,McCarthyMI, Zoldo͉ V, Spector TD, Lauc G, Valdes AM: Glycosylation of immunoglobulin g: role of genetic and epigenetic influences. PLoS ONE 8: e82558, 2013
25. Pivac N, Knezevic A, Gornik O, Pucic M, Igl W, Peeters H, Crepel A, Steyaert J, Novokmet M, Redzic I, Nikolac M, Hercigonja VN, Curkovic KD, Curkovic M, Nedic G, Muck-Seler D, Borovecki F, Rudan I, Lauc G: Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders. Mol Cell Proteomics 10: M110 004200, 2011.
26. Novokmet M, Lukic E, Vuckovic F, Duric Z, Keser T, Raj͉l K, Remondini D, Castellani G, Ga͉parovic H, Gornik O, Lauc G: Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci Rep 4: 4347, 2014
27. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K, Takeuchi F, Nagano Y, Miyamoto T, Kobata A: Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316: 452-457, 1985
28. Kri͉tic J, Vuckovic F, Menni C, Klaric L, Keser T, Beceheli I, Pucic-BakovicM, Novokmet M, Mangino M, Thaqi K, Rudan P, Novokmet N, Sarac J, Missoni S, Kolcic I, Pola͉ek O, Rudan I, Campbell H, Hayward C, Aulchenko Y, Valdes A, Wilson JF, Gornik O, Primorac D, Zoldo͉ V, Spector T, Lauc G: Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci 69: 779-789, 2014
29. Mihai S, Nimmerjahn F: The role of Fc receptors and complement in autoimmunity. Autoimmun Rev 12: 657-660, 2013
30. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB: Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binDing protein. Nat Med 1: 237-243, 1995
31. Cook HT: Complement and kidney disease. Curr Opin Nephrol Hypertens 22: 295-301, 2013
32. Rombouts Y, Ewing E, van de Stadt LA, SelmanMH, Trouw LA, Deelder AM, Huizinga TW, Wuhrer M, van Schaardenburg D, Toes RE, Scherer HU: Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis 74: 234-241, 2015
33. Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, O'Donnell CI, Derber LA, Weinblatt ME, Shadick NA, Bell DA, Cairns E, SolomonDH,HolersVM, RuddPM, LeeDM:Aberrant IgGgalactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 62: 2239-2248, 2010
34. Tomana M, Schrohenloher RE, Koopman WJ, Alarcón GS, Paul WA: Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 31: 333-338, 1988
35. Tomana M, Schrohenloher RE, Reveille JD, Arnett FC, Koopman WJ: Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases. Rheumatol Int 12: 191-194, 1992
36. Anthony RM, Ravetch JV: A novel role for the IgG Fc glycan: the antiinflammatory activity of sialylated IgG Fcs. J Clin Immunol 30[Suppl 1]: S9-S14, 2010
37. Kaneko Y, Nimmerjahn F, Ravetch JV: Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313: 670-673, 2006
38. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV: Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320: 373-376, 2008
39. Huffman JE, Pucic-Bakovic M, Klaric L, Hennig R, SelmanMH, Vuckovic F, Novokmet M, Kri͉tic J, BorowiakM,Muth T, Pola͉ek O, Razdorov G, Gornik O, Plomp R, Theodoratou E, Wright AF, Rudan I, Hayward C, Campbell H, Deelder AM, Reichl U, Aulchenko YS, Rapp E, Wuhrer M, Lauc G: Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13: 1598-1610, 2014
40. Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU,Orr SJ, BergerM, Petzold D, Blanchard V,Winkler A, Hess C, Reid DM, Majoul IV, Strait RT, Harris NL, Köhl G, Wex E, Ludwig R, Zillikens D, Nimmerjahn F, Finkelman FD, Brown GD, Ehlers M, Köhl J: Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgRIIB and dectin-1. Nat Med 18: 1401-1406, 2012
41. FerraraC, Stuart F, Sondermann P, Brünker P,Umaña P: The carbohydrate at FcgammaRIIIaAsn-162. Anelement requiredfor high affinity binDing to non-fucosylated IgG glycoforms. J Biol Chem281: 5032-5036, 2006
42. Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O, Gornik O, Supraha-Goreta S, Wormald MR, Redzic I, Campbell H, Wright A, Hastie ND,Wilson JF, Rudan I,Wuhrer M, Rudd PM, Josic D, Lauc G: High throughput isolation and glycosylation analysis of IgGvariability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10: M111 010090, 2011.
43. MasudaK, KubotaT, KanekoE, IidaS,WakitaniM, Kobayashi-Natsume Y, Kubota A, Shitara K, Nakamura K: Enhanced binDing affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Mol Immunol 44: 3122-3131, 2007
44. Moayyeri A, Hammond CJ, Valdes AM, Spector TD: Cohort Profile: TwinsUK and healthy ageing twin study. Int J Epidemiol 42: 76-85, 2013
45. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
46. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members: Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158: 825-830, 2013